Investigation for the effect of duloxetine on adolescent depression; Ver. 2

Trial Profile

Investigation for the effect of duloxetine on adolescent depression; Ver. 2

Discontinued
Phase of Trial: Phase II

Latest Information Update: 04 Jul 2017

At a glance

  • Drugs Duloxetine (Primary)
  • Indications Major depressive disorder
  • Focus Therapeutic Use
  • Acronyms E-DAD
  • Most Recent Events

    • 30 Jun 2017 Planned End Date changed from 31 May 2017 to 31 Mar 2017.
    • 30 Jun 2017 Status changed from recruiting to discontinued.
    • 12 Apr 2015 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top